OTC Records Inspection Concerns Raised At FDA, CHPA Meeting
This article was originally published in The Tan Sheet
Executive Summary
Potential industry concerns regarding implementation of the FDA Modernization Act's new OTC records inspection provisions were raised during an "explor-atory" meeting between FDA and the Consumer Healthcare Products Association Sept. 15.
You may also be interested in...
FDA inspection of OTC company records expected after "time, guidance" given industry.
FDA INSPECTION OF OTC COMPANY RECORDS is expected to begin only after the agency has provided "sufficient time and guidance" to the OTC drug industry, according to a conference committee "explanatory statement" on the major FDA reform bill, the FDA Modernization Act of 1997, that passed the House and Senate Nov. 9. The bill provides FDA with new authority to inspect OTC drug facilities and records to the same extent as prescription drugs.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands